Quick Answer
GLOBUS MEDICAL INC reported Research And Development Expense of $147.25 million for the year ending 2025.
- GLOBUS MEDICAL INC showed a decrease of -10.1% in Research And Development Expense from 2024 to 2025.
- This data is from GLOBUS MEDICAL INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), GLOBUS MEDICAL INC's Research And Development Expense has grown by 591.0%.
- Historical annual values: Fiscal year 2025: $147.25 million | Fiscal year 2024: $163.75 million | Fiscal year 2023: $124.01 million | Fiscal year 2022: $73.02 million | Fiscal year 2021: $97.35 million | Fiscal year 2020: $84.52 million | Fiscal year 2019: $60.07 million | Fiscal year 2018: $55.50 million | Fiscal year 2017: $43.68 million | Fiscal year 2016: $44.53 million | Fiscal year 2015: $36.31 million | Fiscal year 2014: $31.17 million | Fiscal year 2013: $26.87 million | Fiscal year 2012: $27.93 million | Fiscal year 2011: $23.46 million | Fiscal year 2010: $21.31 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: